SCHEMBL4397923

SCHEMBL4397923

CCN(CC)/C(C)=N/C(=S)NC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 3/20 0.36
EHMT1 Q9H9B1 3/20 0.36
ABCB11 O95342 2/20 0.36
HTT P42858 2/20 0.36
GSDMD P57764 2/20 0.36
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
CA9 Q16790 2/20 0.36
CYP2E1 P05181 1/20 0.36
PTGS1 P23219 1/20 0.36
PHGDH O43175 2/20 0.34
MGLL Q99685 2/20 0.34
PLIN1 O60240 1/20 0.34
GMNN O75496 1/20 0.34
TRPA1 O75762 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4398332 1.00 EHMT2 (0.36) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL4395498 0.76 ALDH1A1 (0.37) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL4395496 0.76 ALDH1A1 (0.37) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL4394289 0.71 NPC1 (0.49) ALDH1A1CYP1A2CYP3A4MAPTHPGD
SCHEMBL4395390 0.70 ALDH1A1 (0.51) HTTALDH1A1CYP1A2CYP3A4MAPT
SCHEMBL4394381 0.69 ALDH1A1 (0.55) ALDH1A1LMNAMAPTKMT2ANPSR1
SCHEMBL4393516 0.69 ALDH1A1 (0.55) ALDH1A1LMNAMAPTKMT2ANPSR1
SCHEMBL4393306 0.67 GLA (0.50) MGLLALDH1A1MAPTHPGDKMT2A
SCHEMBL12604509 0.66 EHMT2 (0.33) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL8392148 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829014-B2 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2014-09-09 US disclosed
EP-2007393-B1 THIAZOLE AND THIOPHENE ANALOGUES, AND THEIR USE IN TREATING AUTOIMMUNE DISEASES AND CANCERS UNIV LOUISIANA STATE (US) 2013-08-21 EP disclosed
US-20120283268-A1 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers GIORDANO ANTHONY (US) 2012-11-08 US disclosed
US-8217037-B2 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2012-07-10 US disclosed
US-20090306073-A1 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers B.V. PATEL PHARMACEUTICAL EDUCATION & RESEARCH DEVELOPMENT (PERD) CENTRE (IN) 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306073-A1 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers TPMT, TST, SSB EHMT2 1509/4885EHMT1 1684/4885ABCB11 4422/4885
US-20120283268-A1 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers TPMT, TST, SSB EHMT2 1509/4885EHMT1 1684/4885ABCB11 4422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.